Related Experiment Video
Updated: Jun 24, 2026
Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
Published on: January 18, 2018
Thrombolytic therapy in central retinal artery occlusion: cutting edge therapy, standard of care therapy, or
Ribhi Hazin1, James A Dixon, M Tariq Bhatti
1Faculty of Arts and Sciences, Harvard University, Cambridge, Massachusetts, USA.
Insights
Thrombolytic therapy shows promise for central retinal artery occlusion (CRAO) if given promptly. However, more randomized controlled trials are needed to confirm its effectiveness as a standard treatment for CRAO.
Area of Science:
- Ophthalmology
- Vascular Medicine
- Emergency Medicine
Background:
- Central retinal artery occlusion (CRAO) lacks a universally effective treatment.
- Current therapies include ocular massage, anterior chamber paracentesis, and IOP reduction.
- There is a significant need for novel and effective therapeutic strategies for CRAO.
Purpose of the Study:
- To review the current progress and evidence regarding thrombolytic therapy for CRAO.
- To evaluate the potential of thrombolytic agents as a treatment for central retinal artery occlusion.
- To provide an update on emerging therapeutic options for CRAO.
Main Methods:
- Literature review of studies investigating thrombolytic therapy in CRAO.
- Analysis of case reports, case series, and any available randomized controlled trials.
- Synthesis of evidence on the efficacy and safety of thrombolytic treatment for CRAO.
Main Results:
- Emerging evidence suggests prompt thrombolytic therapy may be beneficial for CRAO.
- Case reports and series indicate potential efficacy, but lack of standardization exists.
- Randomized controlled studies are essential to validate these preliminary findings.
Conclusions:
- Thrombolytic therapy is not yet a validated or standard treatment for CRAO.
- Further high-quality randomized controlled trials are critically needed.
- Establishing thrombolytic therapy as a standard of care requires robust clinical evidence.
Purpose Of Review:
Numerous therapeutic options have been suggested for the treatment of central retinal artery occlusion (CRAO) such as ocular massage, anterior chamber paracentesis, physical exercise, and medication-induced reduction of intraocular pressure. Because of the lack of a proven effective treatment for CRAO, there has been a strong effort to develop alternative therapies. Recently, thrombolytic therapy has been suggested as a viable therapy for CRAO. The aim of this review is to provide an update on the progress of thrombolytic therapy for CRAO.
Recent Findings:
Although there is no consensus on a standardized treatment regimen for CRAO, emerging evidence suggests that thrombolytic therapy may be effective if administered promptly. Despite the benefit of thrombolytic therapy, on the basis of the results of case reports and case series, randomized controlled studies are necessary to ultimately prove the effectiveness of the treatment.
Summary:
Thrombolytic therapy has yet to be validated as an effective treatment of CRAO. The execution of randomized, controlled trials is greatly needed to establish whether thrombolytic therapy can be considered standard of care therapy for CRAO.
Related Concept Videos
01:29Venous Thrombosis III: Interprofessional Care
01:27Peripheral Artery Disease III: Interprofessional Care
01:29Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
01:27Coronary Artery Disease V: Interprofessional Care
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
01:28Acute Coronary Syndrome IV: Interprofessional Care